MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2026 International Congress

October 4-8, 2026. Seoul, Korea.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Omaveloxolone in a real-world setting: implications in Friedreich Ataxia beyond the classic study population

    W. Nachbauer, M. Amprosi, D. Boesch, M. Schranz, E. Indelicato, L. Schwaighofer, S. Boesch (Innsbruck, Austria)

  • One day accelerated 10 Hz rTMS for Focal Hand Dystonia: A Phase II Clinical Trial

    I. Xu, Z. Simsek, P. Mulcahey, C. Bui, Y. Li, N. Hamzah, A. Norain, M. Lipp, D. Bitlis, S. Dave, K. Grozev, C. Russell, C. Petty, M. Lutz, A. Peterchev, N. Bukhari-Parlakturk (Durham, USA)

  • One-Year Outcomes of Radiofrequency Thalamotomy Versus MR-Guided Focused Ultrasound: A Prospective Single-Centre Comparative Study

    M. Mohamad, S. Idris, J. Candelario-Mckeown, C. Hartigan, J. Esperida, M. Salazar, J. Hyam, T. Foltynie, H. Akram, P. Limousin, M. Krueger, L. Zrinzo, S. Xu (London, United Kingdom)

  • One-Year Trajectories of Non-Motor Symptoms in Parkinson’s Disease: A Longitudinal Cohort Study Using the MDS-NMS with Age at Onset Stratification

    D. Faldu, S. Prasad, T. Nagaraj, S. Bhat, M. Bhardwaj, SS. Aramugham, K. Kumar, R. Mahale, P. Mailankody, V. Holla, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

  • Online Assessments Measure Motor and Cognitive Progression in People with and without Parkinson’s Disease

    E. Brown, X. Chen, P. Gonzalez Latapi, D. Weintraub, C. Marras, N. Pavese, L. Chahine, W. Poewe, R. Dobkin, K. Chou, E. Tolosa, A. Noyce, C. Stanley, T. Tropea, L. Racelo, M. Korell, K. Marek, C. Tanner (San Francisco, USA)

  • Opicapone as adjunct to levodopa in Chinese patients with Parkinson’s disease and wearing-off: a randomized, double-blind, placebo-controlled phase 3 trial

    S. Chen, Y. Tan (Shanghai, China)

  • Opicapone Co-administration Allows Significant Flow Reduction in Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion: A Real-World Case Series

    G. Tabar Comellas, N. Lopez Ariztegui, M. Morales Casado (TOLEDO, Spain)

  • Opicapone for Management of Sleep Disturbances in Parkinson’s Disease: Post-hoc Analysis of the OASIS trial in Patients With and Without Probable RBD

    G. Banisadr, J. Ferreira, M. Gago, R. Costa, M. Fonseca, H. Brigas, S. Fisher, J. Holenz, C. Trenkwalder (Bridgewater, USA)

  • Opsoclonus-Myoclonus-Ataxia Syndrome in Adults: Case Series in Vietnam

    N. Bui, C. Luong, K. Vo (Ha Noi, Viet Nam)

  • Optimal and invariant hierarchical cognitive indices in the Parkinson’s Progression Markers Initiative

    D. González, W. Kent, G. Springer, A. Karstens (Chicago, USA)

  • « Previous Page
  • 1
  • …
  • 137
  • 138
  • 139
  • 140
  • 141
  • …
  • 208
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley